UK Health Radio Podcast
UK Health Radio Podcast
10: Peter Hofland, Ph.D - The Onco’Zine Brief - Episode 2
10: Peter Hofland, Ph.D - The Onco’Zine Brief - Episode 2
10: Peter Hofland, Ph.D - The Onco’Zine Brief - Episode 2
Sunday 29th January 2023
Steven Spellman talks about revolutionary advancements in bone marrow transplants on the Onco'Zine Brief podcast on UK Health Radio.
40 minutes
Informative
Hopeful
Educational
Supportive
Transformative
About this podcast
Overview:
Categories:
Mindfulness & Emotional Wellbeing
Spiritual & Personal Growth Journeys
Mindful Recovery
Entrepreneurship for Personal Growth
Navigating Intimate Relationships
Links:
Visit site
Episodes:
2806 (View all)
Do you want to link to this podcast?
Get the buttons here!Breakthroughs in Bone Marrow Transplants with Steven Spellman
So we're excited to see where this takes us in the future.
Ever wondered how mismatched bone marrow donors could save lives? In this milestone episode of the Onco'Zine Brief on UK Health Radio, Peter Hofland chats with Steven Spellman, the Vice President of Research at the National Marrow Donor Program. Spellman dives into the fascinating world of bone marrow transplants, shedding light on groundbreaking advancements in HLA mismatching that are set to revolutionize patient care. With these new developments, more patients can find suitable donors, eliminating previous barriers to transplantation.
The conversation also covers the impact of graft-versus-host disease, the role of clinical trials, and efforts to reduce disparities in access to transplants. Spellman highlights the importance of patient services programs that offer financial grants and the vital support provided by social workers throughout the transplant journey. Additionally, he discusses strategies for reducing toxicity and ensuring thorough follow-up care. This episode is a treasure trove of information for anyone keen on the latest strides in cancer treatment.
Tune in for an enlightening discussion that could change the future of bone marrow transplants.